JW (Cayman) Therapeutics Co. Ltd.'s total assets for Q2 2025 were ¥1.42B, a decrease of -15.53% from the previous quarter. HK:2126 total liabilities were ¥510.83M for the fiscal quarter, a -0.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.